117 results in Exploration of Drug Science
Most Cited
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Review
Synthetic peptides as valuable and versatile tools for research: our 20 year journey in Chile
Constanza Cárdenas ... Fanny Guzmán
Published: October 15, 2024 Explor Drug Sci. 2024;2:701–718
This article belongs to the special issue Bioactive Peptides: Pioneering Innovations in Latin American Research
Open Access
Original Article
Bicyclic peptide-enhanced covalent inhibitor of SARS-CoV-2 3CL protease
Qian Wang ... Shiyu Chen
Published: October 17, 2024 Explor Drug Sci. 2024;2:719–733
This article belongs to the special issue Bioactive Peptides discovery and development
Open Access
Mini Review
Pain management for the neurosurgical patient in spinal procedures: overview of historic and new modalities
Ashley M. Carter ... Brandon Lucke-Wold
Published: May 21, 2024 Explor Drug Sci. 2024;2:268–276
Open Access
Original Article
Enhanced breast cancer cell targeting: RGD integrin ligand potentiates RWQWRWQWR’s cytotoxicity and inhibits migration
Andrea Barragán-Cárdenas ... Javier García-Castañeda
Published: July 19, 2024 Explor Drug Sci. 2024;2:369–388
This article belongs to the special issue Bioactive Peptides: Pioneering Innovations in Latin American Research
Open Access
Review
Natural products as anticancer agents and enhancing their efficacy by a mechanism-based precision approach
Stephen Safe
Published: July 30, 2024 Explor Drug Sci. 2024;2:408–427
This article belongs to the special issue Exploring Potential Drugs from Natural Products
Open Access
Review
Decoding vascular aging: implications for atherosclerosis progression and clinical intervention
Silumbwe Ceaser Wankumbu ... Ming Xu
Published: August 02, 2024 Explor Drug Sci. 2024;2:449–472
Open Access
Review
What are biopharmaceuticals?
Abhay H. Pande ... J. Anakha
Published: January 10, 2025 Explor Drug Sci. 2025;3:100880
Open Access
Review
Sirtuin activators as an anti-aging intervention for longevity
Puja Sah ... Donkupar Syiem
Published: January 12, 2025 Explor Drug Sci. 2025;3:100881
This article belongs to the special issue Recent advances with investigational compounds and strategies to delay or reverse normal aging processes
Open Access
Original Article
Phenylalanine-derived β-lactam TRPM8 antagonists: revisiting configuration and new benzoyl derivatives
Cristina Martín-Escura ... Rosario González-Muñiz
Published: January 13, 2025 Explor Drug Sci. 2025;3:100882
This article belongs to the special issue Mimicking Nature: Biomimetics as Tools for Diagnosis and Therapeutics
Open Access
Review
Unlocking the therapeutic potential of protein kinase inhibitors in neurodegenerative and psychiatric disorders
Angela Asir R V ... Izhak Michaelevski
Published: February 26, 2025 Explor Drug Sci. 2025;3:100892
This article belongs to the special issue Leveraging the FDA-Approved Kinase Inhibitors to Treat Neurological Disorders
Open Access
Original Article
Prediction of drug exposure in hepatic impairment: a comparison between minimal physiologically based pharmacokinetic (mPBPK) and whole body PBPK models
Iftekhar Mahmood
Published: February 27, 2025 Explor Drug Sci. 2025;3:100894
Open Access
Original Article
Efficacy of propolis varnish in reducing Streptococcus mutans counts
Mariana Passos De Luca ... Vagner Rodrigues Santos
Published: March 20, 2025 Explor Drug Sci. 2025;3:100899
Open Access
Review
Natural products targeting cancer stem cells: a promising therapeutic approach
Julia K. Opara ... Shrikant Anant
Published: April 18, 2025 Explor Drug Sci. 2025;3:1008106
This article belongs to the special issue Remedial benefits of natural products in inflammation and cancer
Open Access
Editorial
Machine learning for drug science
Walter F. de Azevedo Jr.
Published: April 16, 2023 Explor Drug Sci. 2023;1:77–80
This article belongs to the special issue Machine Learning for Drug Science
Open Access
Original Article
Properties of new polycationic bacteriochlorin photosensitizers: cytotoxicity and interaction with biofilms
Irina Tiganova ... Yulia Romanova
Published: September 27, 2024 Explor Drug Sci. 2024;2:632–647
This article belongs to the special issue Discovery and development of new antibacterial compounds
Open Access
Original Article
Levistolide A and periplogenin inhibit the growth of gastric cancer cells in vitro and in vivo
Jia Li Guo ... Ji Zhong Zhao
Published: March 30, 2023 Explor Drug Sci. 2023;1:64–76
This article belongs to the special issue Exploring Potential Drugs from Natural Products
Open Access
Review
Iron depletion in “metabolic fatty liver syndromes”: a strong biological rationale with disappointing liver outcomes
Amedeo Lonardo
Published: August 28, 2023 Explor Drug Sci. 2023;1:239–252
Open Access
Original Article
In silico study about β-amyloid’s role in Alzheimer’s disease and glaucoma and prediction of its interactions with glaucoma related proteins
Nancy Maurya
Published: August 29, 2023 Explor Drug Sci. 2023;1:276–286
This article belongs to the special issue Machine Learning for Drug Science
Open Access
Case Report
Single or multiple treatments with lusutrombopag in subjects with thrombocytopenia and chronic liver disease needing an invasive procedure
Davide Scalabrini ... Pietro Andreone
Published: August 30, 2023 Explor Drug Sci. 2023;1:292–298
This article belongs to the special issue Innovative Therapeutics in Hepato-Gastroenterology
Open Access
Editorial
Drug discovery: a multifactorial ecosystem
Fernando Albericio
Published: January 01, 2023 Explor Drug Sci. 2023;1:1–5
Journal Information